enCore Energy Corp. (EU) SEC Filings & Earnings Calls
EquiReason read 14 enCore Energy Corp. SEC filings in the last 12 months. Latest: 8-K on 2026-08-13 — Net loss per share $-0.19 (+19% y/y); Uranium deliveries 485,000 (+39% y/y); Average sales price per pound $70.10 (+12% y/y).
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 136.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
13 Aug 20268-K · 2.02Net loss per share $-0.19 (+19% y/y); Uranium deliveries 485,000 (+39% y/y); Average sales price per pound $70.10 (+12% y/y)earningsopen
Figures in the filing · each found in the filing text
| Net loss per share · H1-2026 | $-0.19 | +19% y/y |
| Uranium deliveries · H1-2026 | 485,000 | +39% y/y |
| Average sales price per pound · H1-2026 | $70.10 | +12% y/y |
| Weighted average cost of delivered U3O8 · H1-2026 | $75.54 | +27% y/y |
| Uranium extraction · H1-2026 | 131,274 | -59% y/y |
| Extraction costs per pound · H1-2026 | $57.36 | +34% y/y |
| Uranium inventory · H1-2026 | 203,304 | -17% y/y |
| Total liquidity · H1-2026 | $88M | |
| Adjusted total liquidity · H1-2026 | $74M |
Risks flagged
Negative operating margin: cost of sales exceeds sales price
“Weighted average cost of delivered U3O8 increased to $75.54 per pound... average sales price of $70.10 per pound”
Significant production decline due to wellfield depletion and permitting delays
“U3O8 extraction of 131,274 pounds, a decrease from 317,613 pounds... Alta Mesa's Wellfield 7 is scheduled to cease recovery during Q3-2026 due to anticipated depletion”
Permitting delays for new wellfields could prolong production issues
“Final permitting to begin extraction operations from Wellfield 3 Extension is anticipated in Q4-2026... Final permits for Wellfield 8 are anticipated by the end of Q1-2027” · word for word
Workforce reduction indicates cost pressures
“In July 2026, management executed on its plan for reducing costs with a reduction in workforce following a rationalization of staffing needs across the Company.” · word for word
13 Aug 202610-QenCore Energy reported Q2 2026 revenue of $15.7M, up 328% YoY, but net loss widened to $44.6M due to higher costs and permitting delays.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $16M | +328% y/y |
| Volumes sold (lbs.) · Q2-2026 | 215,000 | +258% y/y |
| Realized sales price ($/lb.) · Q2-2026 | $73.00 | +20% y/y |
| Weighted avg. costs applicable to revenues ($/lb.) · Q2-2026 | $84.99 | +101% y/y |
| Net loss · Q2-2026 | $-45M | +405% y/y |
| Cash and cash equivalents · 2026-06-30 | $22M | -58% y/y |
| Working capital · 2026-06-30 | $87M | -9% y/y |
| Total cost of inventory (lbs.) · 2026-06-30 | 203,304 | +54% y/y |
| Extracted total cost per lb · H1-2026 | $57.36 | +34% y/y |
Guidance
Reduced overall production estimates for 2026 due to permitting delays
Management reduced 2026 production estimates due to permitting delays but remains committed to cost efficiency and production optimization.
Risks flagged
Permitting delays
“The Company continues to be impacted by delays in the permitting approval process associated with its assets in South Texas, including Alta Mesa and Upper Spring Creek. These delays have resulted in reduced overall production estimates for the year ending December 31, 2026.” · word for word
Negative gross margin on sales
“Costs applicable to uranium sales were $18,272 for the three months ended June 30, 2026, related to the completed sale of 215,000 pounds of uranium at a weighted average cost of $84.99 per pound” · word for word
Cash burn
“Net cash used in operating activities increased by $24,873 from $17,629 for the six months ended June 30, 2025 to $42,502 for the six months ended June 30, 2026.” · word for word
9 Jul 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen
Risks flagged
CEO departure may signal leadership instability or strategic shift.
“terminated Robert J. Willette from his position as the Company’s Chief Executive Officer” · word for word
14 May 202610-QRevenue $18M (+0% y/y); Net income (loss) attributable to enCore Energy Corp. $5M; Operating cash flow $-21Mopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $18M | +0% y/y |
| Net income (loss) attributable to enCore Energy Corp. · Q1-2026 | $5M | |
| Operating cash flow · Q1-2026 | $-21M | |
| Cash and cash equivalents · 2026-03-31 | $42M | |
| Total debt (convertible senior notes) · 2026-03-31 | $110M | |
| EPS (basic and diluted) · Q1-2026 | $0.03 |
Risks flagged
Negative gross margin
“Gross profit (loss) $(64) for the three months ended March 31, 2026.”
Operating cash flow negative
“Net cash used in operating activities $(21,426) for the three months ended March 31, 2026.” · word for word
Unrealized loss on marketable securities
“Loss on marketable securities, unrealized $(10,048) for the three months ended March 31, 2026.”
Litigation risk
“On March 14, 2025, a purported shareholder of the Company filed a putative federal securities class action... Management believes that this litigation is preliminary in nature and the Company believes that an adverse outcome is not probable or estimable at this time.” · word for word
14 May 20268-K · 2.02Net income per share $0.03; U3O8 delivered 270,000 (-7% y/y); U3O8 extraction 90,000 (+22% y/y)earningsopen
Figures in the filing · each found in the filing text
| Net income per share · Q1-2026 | $0.03 | |
| U3O8 delivered · Q1-2026 | 270,000 | -7% y/y |
| U3O8 extraction · Q1-2026 | 90,000 | +22% y/y |
| Average sales price per pound · Q1-2026 | $67.78 | +8% y/y |
| Weighted average cost of delivered U3O8 · Q1-2026 | $68.02 | +8% y/y |
| Extraction cost per pound · Q1-2026 | $46.43 | +2% y/y |
| Cash and equivalents · Q1-2026 | $42M | |
| Total liquidity · Q1-2026 | $85M |
Risks flagged
Cost per pound increased, indicating margin pressure.
“Weighted average cost of delivered U3O8 $68.02 vs $62.97.”
30 Apr 2026DEF 14AAnnual proxy statement revealing significant CEO turnover, net losses, declining shareholder returns, and related party transactions.open
Figures in the filing · each found in the filing text
| Net Income · FY2025 | $-63M | |
| Total Shareholder Return (Cumulative) · FY2025 | $90.00 |
Risks flagged
CEO turnover and transition risk
“Mr. Goranson ceased serving as Chief Executive Officer and Director of the Company on March 2, 2025. ... Mr. Willette ceased serving as Chief Executive Officer of the Company on April 20, 2026.” · word for word
Related party transactions and governance risk
“the Company incurred consulting fees of $183,000 related to a contract with Powerhaus Gruppe Corp, a company owned and operated by a family member of the Company's Executive Chairman.” · word for word
Financial performance risk
“Net Income ... 2025 ... (63,023)”
Shareholder return risk
“Value of initial fixed $100 investment based on Total Shareholder Return ($) ... 2025 ... 90” · word for word
20 Apr 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Leadership transition risk; new CEO with prior energy sector experience but no uranium-specific background
“CEO previously at Permex Petroleum, Fury Resources, Battalion Oil; no direct uranium mining experience”
9 Mar 20268-K · 2.02U3O8 extraction 699,807 (+242% y/y); U3O8 sales (delivery) 655,000; Average sales price $65.89earningsopen
Figures in the filing · each found in the filing text
| U3O8 extraction · FY2025 | 699,807 | +242% y/y |
| U3O8 sales (delivery) · FY2025 | 655,000 | |
| Average sales price · FY2025 | $65.89 | |
| Weighted average cost of sales · FY2025 | $51.09 | |
| U3O8 inventory (closing) · FY2025 | 132,013 | |
| Cash and cash equivalents · FY2025 | $52M | |
| Total liquidity · FY2025 | $96M | |
| Net loss per share · FY2025 | $-0.30 | -12% y/y |
Risks flagged
Regulatory delays at Upper Spring Creek could impact production growth; reliance on TCEQ approvals.
“Upper Spring Creek permitting delayed; company contracted additional inventory to satisfy 2026 obligations.”
Uranium price volatility and nuclear fuel supply chain risks.
“Company exposed to uranium market prices; sales price $65.89/lb.”
2 Mar 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Leadership transition risk is low as founder remains in advisory role and no disagreement cited.
“Mr. Sheriff's resignation is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices nor will it result in any separation benefits.” · word for word
18 Feb 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportopen
Risks flagged
Distribution dependent on SEC registration and business combination closing; execution risk.
“Distribution subject to effectiveness of resale registration statement and completion of Verdera business combination with POCML 7.”
2 Dec 20258-K · 1.01, 5.02, 7.01, 8.01Annual director fee $70,000.00; restricted stock units granted 25,000; stock options granted 100,000open
Figures in the filing · each found in the filing text
| annual director fee · FY2025 | $70000.00 | |
| restricted stock units granted · Q4-2025 | 25,000 | |
| stock options granted · Q4-2025 | 100,000 | |
| stock option exercise price · Q4-2025 | $2.73 | |
| common shares sale limit per month (10b5-1) · Q4-2025 | 24,000 |
Risks flagged
Going public delay risk: Extension of Verdera's listing deadline may indicate challenges in completing the transaction, potentially affecting value of Consideration Shares.
“Going Public Outside Date extended to February 23, 2026, from December 10, 2025.”
Insider selling: Executive Chairman adopted 10b5-1 plan for monthly sales of up to 24,000 shares, which could signal personal liquidity needs or perceived overvaluation.
“William M. Sheriff adopted a Rule 10b5-1 trading arrangement for the sale of up to 24,000 common shares per calendar month.”
12 Nov 20258-K · 2.02Net loss per share $-0.03; U3O8 extraction 227,070; U3O8 sold (delivery) 130,000earningsopen
Figures in the filing · each found in the filing text
| Net loss per share · Q3-2025 | $-0.03 | |
| U3O8 extraction · Q3-2025 | 227,070 | |
| U3O8 sold (delivery) · Q3-2025 | 130,000 | |
| Average price U3O8 sold · Q3-2025 | $68.28 | |
| Weighted average cost U3O8 sold · 9M-2025 | $53.71 | |
| Cash and cash equivalents · Q3-2025 | $100M | |
| U3O8 inventory · Q3-2025 | 287,089 |
10 Nov 202510-QQ3 2025 results: revenue slightly down YoY but gross profit turned positive; company raised $115M via convertible notes.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $9M | -4% y/y |
| Net loss attributable to enCore Energy Corp. · Q3-2025 | $-5M | +70% y/y |
| Cash and cash equivalents · 2025-09-30 | $92M | |
| Total debt (convertible senior notes) · 2025-09-30 | $109M | |
| EPS (basic and diluted) · Q3-2025 | $-0.03 | +67% y/y |
Risks flagged
Exploration stage issuer without proven reserves
“As of September 30, 2025, the Company is an 'Exploration Stage Issuer' as defined by Regulation S-K subpart 1300...as it has not established proven or probable mineral reserves.” · word for word
Negative operating cash flow
“Net cash used in operating activities $37,927 for the nine months ended September 30, 2025.”
enCore Energy Corp. — questions
- What did enCore Energy Corp. file recently?
- 14 SEC filings in the last 12 months. Latest: 8-K on 2026-08-13 — Net loss per share $-0.19 (+19% y/y); Uranium deliveries 485,000 (+39% y/y); Average sales price per pound $70.10 (+12% y/y)
Every figure on this page comes from enCore Energy Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.